SARS-CoV-2 infection as a potential trigger factor for de novo occurrence of inflammatory bowel disease.

Tursi, Antonio; Lopetuso, Loris Riccardo; Vetrone, Lorenzo Maria; Gasbarrini, Antonio; Papa, Alfredo

Tursi, Antonio; Lopetuso, Loris Riccardo; Vetrone, Lorenzo Maria; Gasbarrini, Antonio; Papa, Alfredo.

Tursi A; Territorial Gastroenterology Service, ASL BAT, Andria.
Lopetuso LR; Department of Medicine and Surgery, Post-Graduate School of Digestive Disease, Catholic University, Rome.
Vetrone LM; Department of Medicine and Ageing Sciences, "G. d'Annunzio" University of Chieti- Pescara.
Gasbarrini A; Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti.
Papa A; CEMAD, Digestive Disease Center, Fondazione Policlinico A. Gemelli, IRCCS.

Eur J Gastroenterol Hepatol ; 34(8): 883-884, 2022 08 01.

Article in English | MEDLINE | ID: covidwho-2051709

Subject(s)

COVID-19; Inflammatory Bowel Diseases; Humans; Inflammatory Bowel Diseases/epidemiology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Eur J Gastroenterol Hepatol Journal subject: Gastroenterology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google